EGF Antikörper (AA 926-1025)
Kurzübersicht für EGF Antikörper (AA 926-1025) (ABIN560702)
Target
Alle EGF Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 926-1025
-
Verwendungszweck
- Mouse polyclonal antibody raised against a partial recombinant EGF.
-
Sequenz
- NASCTNTEGG YTCMCAGRLS EPGLICPDST PPPHLREDDH HYSVRNSDSE CPLSHDGYCL HDGVCMYIEA LDKYACNCVV GYIGERCQYR DLKWWKLRHA
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- EGF (NP_001954, 926 a.a. ~ 1025 a.a) partial recombinant protein with GST tag.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 50 % glycerol
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
- EGF (Epidermal Growth Factor (EGF))
-
Andere Bezeichnung
- EGF
-
Hintergrund
-
Full Gene Name: epidermal growth factor (beta-urogastrone)
Synonyms: HOMG4,URG -
Gen-ID
- 1950
-
NCBI Accession
- NM_001963
-
Pathways
- NF-kappaB Signalweg, RTK Signalweg, Fc-epsilon Rezeptor Signalübertragung, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation
Target
-